MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors
Clinical trial NCT02699515 · COMPLETED
Trial details
- NCT number
- NCT02699515
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-11
- Primary completion
- 2022-02-21
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.